Assessment of the efficacy and safety of two albendazole regimens for the treatment of hypermicrofilaraemic loiasis in adults in Woleu-Ntem Province, Gabon: A phase IIb single-blind randomised controlled trial.
<h4>Background</h4>Loa (L.) loa hypermicrofilaraemia (≥ 8,000 mf/mL) increases the risk of severe adverse events during mass ivermectin administration for onchocerciasis control. Albendazole has been proposed as a potential alternative for reducing microfilaraemia prior to ivermectin administration....
Kaydedildi:
| Asıl Yazarlar: | , , , , , , , , , , , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Public Library of Science (PLoS)
2026-01-01
|
| Seri Bilgileri: | PLoS Neglected Tropical Diseases |
| Online Erişim: | https://doi.org/10.1371/journal.pntd.0013166 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|